ReviewCardiology research and practice2022

Effect of PCSK9 Inhibitor on Blood Lipid Levels in Patients with High and Very-High CVD Risk: A Systematic Review and Meta-Analysis.

Yue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.